15 years of anti-VEGF treatment for nAMD: success or failure or something in between?-Reference-Cited by-同舟云学术

15 years of anti-VEGF treatment for nAMD: success or failure or something in between?

Published:2022-06-25 Issue:12 Volume:36 Page:2232-2233
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Chakravarthy Usha^ORCID,Armendariz Beatriz G.,Fauser Sascha

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://www.nature.com/articles/s41433-022-02153-9.pdf

Reference27 articles.

1. Causes of Vision Loss. In: The International Agency for the Prevention of Blindness. Sep 2020 [cited 2 Feb 2022]. https://www.iapb.org/learn/vision-atlas/causes-of-vision-loss/

2. Chakravarthy U, Harding SP, Rogers CA, Downes SM, Lotery AJ, Culliford LA, et al. Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial. Lancet 2013;382:1258–67.

3. Bloch SB, Larsen M, Munch IC. Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010. Am J Ophthalmol. 2012;153:209–13.e2.

4. Monés J, Singh RP, Bandello F, Souied E, Liu X, Gale R. Undertreatment of Neovascular Age-Related Macular Degeneration after 10 Years of Anti-Vascular Endothelial Growth Factor Therapy in the Real World: The Need for A Change of Mindset. Ophthalmologica 2020;243:1–8.

5. Daniel E, Toth CA, Grunwald JE, Jaffe GJ, Martin DF, Fine SL, et al. Risk of scar in the comparison of age-related macular degeneration treatments trials. Ophthalmology 2014;121:656–66.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network-based representation learning enables the identification of risk genes and latent functional pathways in primary open-angle glaucoma;2024-08-19

2. Comprehensive functional characterization of complement factor I rare variant genotypes identified in the SCOPE geographic atrophy cohort;Journal of Biological Chemistry;2024-07

3. Real-world service costs for neovascular-AMD clinics in the United Kingdom: structured literature review and scenario analysis;Current Medical Research and Opinion;2024-06-12

4. Association of baseline factors with 1-year outcomes in the SB11-ranibizumab equivalence trial: A post hoc analysis;Asia-Pacific Journal of Ophthalmology;2024-05

5. Analysis of prognostic and predictive factors in neovascular age‐related macular degeneration Kuopio cohort;Acta Ophthalmologica;2024-04-10